Understanding of the pathophysiology of chronic kidney disease (CKD), characterized by kidney fibrosis, through exosome-derived proteomics has been a challenge. We aimed to evaluate the specific biological process revealed by exosome-derived proteomics to gain insights into CKD progression and therapeutic targets